Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people taking Mounjaro move from the 2.5mg starting pen to the 5mg pen after four weeks — but the right moment depends on how your body has settled, not just the calendar. The 2.5mg dose exists purely to let your system adjust; once side effects have eased and you feel comfortable, your prescriber will typically move you up. These medicines are prescription-only, so the decision always sits with a clinician who knows your full picture. What follows explains the process step by step, so you know what to expect and what to notice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first Mounjaro pen contains four weekly 2.5mg doses. Your prescriber will not typically consider a step-up until that pen is finished, not because the calendar is the deciding factor, but because four weeks gives enough time to see how your gastrointestinal system responds. Nausea, reflux, and loose stools are common in the opening days after starting; for most people these settle within one to two weeks.
A quick habit worth building: after each weekly injection, give yourself a rough ten-second check. Is eating still uncomfortable? Are you still running to the bathroom more than twice a day? If the answer is yes by week three, note it down, that information is exactly what your prescriber needs. The full Mounjaro overview covers what the early adjustment period typically looks like.
Do not skip or delay a weekly injection to try to manage side effects, timing changes should always go through your prescriber. The NHS patient information for tirzepatide, available on the NHS medicines page for tirzepatide, sets out what to expect during the starting period and when to contact your clinical team.
When you request your second pen, a clinician at nume reviews your case, a real prescriber reads your answers, not an automated system. They are looking at a specific set of signals: have side effects reduced to a manageable level, is your weight trend in the right direction, and are there any new health factors that need consideration before increasing the dose?
If nausea or vomiting is still disruptive at the end of week four, your prescriber may recommend staying at 2.5mg for another four weeks. That is not a failure, it is the process working correctly. Pushing through to 5mg when your gut has not settled often makes side effects worse and leads people to pause treatment unnecessarily. Understanding what drives dose increases on Mounjaro more broadly can help frame why this caution matters at every step, not just the first.
Evidence from the SURMOUNT-1 trial, published in the New England Journal of Medicine, showed that participants who followed the structured titration schedule achieved the strongest outcomes, the dose ladder is designed to protect tolerability as well as efficacy, and the two are linked.
There is no single test for readiness, but there are reliable indicators. Side effects have become mild or infrequent. You are eating normally (if modestly less than before). You feel confident injecting each week. Your weight has begun to shift, even if only slightly, or you understand that significant loss is not expected at 2.5mg and you are not concerned by its absence.
What readiness does not look like: zero side effects from day one, or dramatic weight loss before moving up. Some people feel almost nothing at 2.5mg; others feel it clearly for two to three weeks. Both are within the normal range. If you are weighing up whether the time is right, the guidance on when to move to 5mg Mounjaro sets out the key factors your prescriber will consider. The practical guidance on moving from 2.5mg to 5mg goes further on what the transition itself typically feels like.
One thing worth knowing: 5mg is where most people notice the appetite-reducing effect becoming more pronounced. Meals feel satisfying sooner, and the urge to snack tends to reduce. That shift can feel significant, which is exactly why the titration is paced the way it is.
Once your prescriber approves the step-up, your 5mg pen is dispensed with the same process as your first: same-day dispatch if ordered before midday Monday to Friday, free next-working-day tracked delivery. Side effects may return briefly after the increase, this is normal and usually settles within one to two weeks, just as it did at the start.
The dose schedule continues in the same pattern from here: four weeks at each level, with a clinical review before each step up. The 5mg Mounjaro dose page covers what to expect at this stage in more detail. For context on how the overall titration ladder works, the guide to timing dose increases on Mounjaro is a useful reference.
Treatment cost changes as doses increase. If you are thinking ahead about the financial side of a longer course, our weight-loss treatment overview explains how pricing works across the dose range.
If you have questions about your specific situation or are unsure whether to step up, our prescribers are available seven days a week. Check your eligibility and start a free consultation, a clinician will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.